We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Integration of High Throughput ‘Omic Platforms into Antibody Discovery

Video   Dec 23, 2016

 

From antibodies to vaccines to T cells, cancer immunotherapy is extending patient lives. Targeted therapies using immune cell receptors can be targeted to either cancer or immune cells. In pursuit of lead structures, ‘omic technologies are revolutionizing the discovery and development of novel biological lead structures. However, ‘omic platforms are first and foremost data generation instruments that require careful integration into workflows. Here, we demonstrate how we have applied next-generation sequencing, big data, biostatistics, and computational immunology to the discovery and development of novel lead structures.

 
 
 
Advertisement
 

Recommended Videos

Giant Spider Provides Promise of Pain Relief for Irritable Bowel Syndrome

Video

Molecules from the venom of one of the world’s largest spiders could help researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

WATCH NOW

Duchenne Muscular Dystrophy and Gene Therapy

Video

The most common form of muscular dystrophy is called Duchenne. The disease is caused by a faulty gene that interferes with how muscle cells produce a protein called dystrophin. It’s part of a vital protein complex that works to strengthen and protect muscle fibers.

WATCH NOW

Gene Therapy: Your Questions Answered

Video

This video aims to address frequently questions, hopes and concerns that patients and caregivers, across many different diseases, have about gene therapy.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE